To inspire and empower millions of people living with Parkinson’s around the world, Bial launches a touching campaign for the World Parkinson’s Day showing that it is possible to live a normal life, and successfully perform everyday tasks
Imagine being unable to control your own body. In your mind, everything is exactly like it was; but your brain seems to have forgotten how to tell your body to do everyday tasks like tying up shoes or using a toothbrush.
This is how it feels to live with Parkinson’s. A real challenge for the 10 million people diagnosed with Parkinson’s around the world. Parkinson’s is a progressive neurodegenerative disease – an illness that affects nerve cells in the brain. For those who live with these symptoms and for their families, Parkinson’s means much more than just physical symptoms: it also means a loss of their independence.
In order to raise awareness and help people keep their self-esteem, people with Parkinson’s were invited to star in a video that shows them at their best by focusing on what they can do instead of what they cannot do. Buttoning up shirts, putting on make-up, tying up shoes or even dancing and playing musical instruments. Simple, everyday tasks alongside a cheerful, feel-good tune developed specially for the campaign.
António Portela, CEO of Bial, explains the positive tone of the campaign: “Parkinson’s can really change people’s lives, but it’s very important that they do not lose their self-esteem. That is why we wanted to counter the negative portraits of people with Parkinson’s and show everyone what they really can do. Hopefully, we can inspire and empower the millions of people living with Parkinson’s to never give up on their dignity. Bial’s aim is to help the lives of people with Parkinson’s even if it’s to help with one small thing at a time.”
The campaign launches worldwide today – on World Parkinson’s Day – and is featured on Bial’s website, across Bial’s social media and on the European Parkinson’s Disease Association’s social media channels too.
Watch the video ‘Me at my best’ below
This article is sponsored by Bial. The information in this article is given for information purposes only and does not represent an endorsement by the EPDA of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
Founded in 1924, Bial’s mission is to discover, develop and provide therapeutic solutions within the area of health. In recent decades, Bial has strategically focused on quality, innovation and internationalisation. Bial has channelled more than 20% of its annual turnover into research and development within neurosciences and the cardiovascular system.
In 2016 Bial launched Opicapone for Parkinson’s disease. Already available in Germany and in the United Kingdom, it will be introduced in the remaining European countries throughout 2017.
Currently representing around two thirds of its turnover, Bial will continue to strengthen its international presence based in its own innovative medicines, particularly in the most important European pharmaceutical markets, Spain, Germany, United Kingdom and Italy, where the company is already present with its own affiliates. For more information about Bial, please visit www.bial.com.
Online video campaign ‘gives life’ to powerful Parkinson’s stories
Campaign calling for inspiring video testimonials from patients
7 days ago
Pig cells implanted into human brain as Parkinson’s treatment
A new treatment, which involves the implantation of pig cells into a human brain, is being tested as a potential treatment for Parkinson’s. The therapy, called NTCELL, has been developed by New Zealand-based biotechnology company Living Cell Technologies, and produces factors that promote central nerve system growth and repair nerve degeneration. Although still in the early stages of testing, the results have been promising with those being treated showing an improvement over an 18-month period. Roger Barker, professor of Clinical Neurosciences at the University of Cambridge, said: “The strategy is a good idea. The question is how competitive that will be compared with other cell therapies.” The treatment could be available as early as 2018.
Fruit flies help shed light on development of Parkinson’s disease
A study carried out by medical students from Juntendo University in Tokyo, Japan, has found that a loss of mitochondrial protein can exacerbate the progression of Parkinson’s disease. The research centred on the study of mutant fruit flies. The team examined what happened to the flies that lacked mitochondrial protein CHCHD2 – a protein that plays a key role in maintaining the structure of cells. The study found that the lack of CHCHD2 led to motor dysfunctions, such as the loss of climbing ability, as the flies aged. However, when researchers introduced a form of human CHCHD2 to the flies, the dysfunctions were reversed. The researchers, led by medical students Hongrui Meng and Chikara Yamashita, said their results shed light on the role of CHCHD2 mutations in Parkinson’s and offer “potential therapeutic targets in Parkinson’s caused by mitochondrial dysfunction.”
3 weeks ago
New research suggests sleep disorders could be early sign of Parkinson’s
New research has found that sleep disorders could be an early warning sign for Parkinson’s. The study, carried out by the University of Toronto, found that 80% of those suffering from rapid eye movement (REM) sleep disorders during dreaming went on to develop neurological conditions. Dr John Peever, who led the study, said: “Our research suggests sleep disorders may be an early warning sign for diseases that may appear some 15 years later in life.” “We observed that more than 80% of people who suffer from REM sleep disorder eventually develop synucleinopathies, such as Parkinson’s disease.” Dr Peever hopes that these findings will help combat neurological conditions in the future. “Much like we see in people prone to cancer, diagnosing REM disorders may allow us to provide individuals with preventative actions to keep them healthy long before they develop these more serious neurological conditions,” Dr Peever continued.